pramipexole 0.125 mg

INDICATIONS & USAGE Parkinson's Disease Pramipexole dihydrochloride tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The effectiveness of pramipexole dihydrochloride tablets was demonstrated in randomized, controlled trials in patients with early Parkinson's disease who were not receiving concomitant levodopa therapy as well as in patients with advanced disease on concomitant levodopa (see CLINICAL STUDIES ).

Watson Pharma, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] death` `[5] diarrhoea` `[6] headache` `[7] dependence` `[8] dyspnoea` `[9] pain` `[10] off label use`

2 years ago

ROUND WHITE PM1

HOW SUPPLIED Pramipexole Dihydrochloride Tablets are available as 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, and 1.5 mg tablets. The 0.125 mg tablet is a white to off-white, round, flat-faced, bevel-edged tablet with “PM1” on one side and “>” on the other side. They are available as follows: Bottles of 90 NDC 0591-3751-19 The 0.25 mg tablet is a white to off-white, oval, flat-faced, bevel-edged tablet with “PM2” score "PM2" on one side and “>" score ">” on the other side. They are available as follows: Bottles of 90 NDC 0591-3752-19 The 0.5 mg tablet is a white to off-white, oval, flat-faced, bevel-edged tablet with “PM3” score "PM3" on one side and “>" score ">” on the other side. They are available as follows: Bottles of 90 NDC 0591-3753-19 The 1 mg tablet is a white to off-white, round, flat-faced, bevel-edged tablet with “PM4” score "PM4" on one side and “>" score ">” on the other side. They are available as follows: Bottles of 90 NDC 0591-3754-19 The 1.5 mg tablet is a white to off-white, round, flat-faced, bevel-edged tablet with “PM5” score "PM5" on one side and “>" score ">” on the other side. They are available as follows: Bottles of 90 NDC 0591-3755-19 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Detach Patient Information Leaflet at each perforation and give leaflet to patient.

More pills like ROUND PM1

Related Pills

pramipexole dihydrochloride tablet

Watson Pharma, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site